ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,694Medicare Part D Prescriptions Filled, Including Refills

Rank: 192 out of 1844

$611K Total Retail Price of All Prescriptions

Rank: 227 out of 1844

323 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 323 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

21% of this provider’s 323 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 9,178 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LEVOTHYROXINE SODIUM 381 362 1 1
FUROSEMIDE 374 347 2 7
HYDROCODONE-ACETAMINOPHEN 347 238 S3 3 2
AMLODIPINE BESYLATE 318 301 4 6
OMEPRAZOLE 280 216 5 5
LISINOPRIL 273 209 6 4
METOPROLOL SUCCINATE 268 253 7 14
POTASSIUM CHLORIDE 211 195 8 16
SIMVASTATIN 210 195 9 3
METFORMIN HCL 204 189 10 8
TRAMADOL HCL 202 165 11 18
DONEPEZIL HCL 178 178 12 26
NAMENDA 174 174 13 33
METOPROLOL TARTRATE 155 155 14 11
BISOPROLOL-HYDROCHLOROTHIAZIDE 148 137 15 99
GABAPENTIN 147 112 16 15
DICLOFENAC SODIUM 122 91 17 122
ISOSORBIDE MONONITRATE ER 122 108 17 59
AZITHROMYCIN 121 96 19 37
CIPROFLOXACIN HCL 121 112 19 62
LISINOPRIL-HYDROCHLOROTHIAZIDE 121 99 19 20
WARFARIN SODIUM 121 114 19 13
KLOR-CON 10 113 98 23 123
GLIPIZIDE ER 104 99 24 79
ALENDRONATE SODIUM 104 102 24 25
ZOLPIDEM TARTRATE 103 83 26 23
CITALOPRAM HBR 102 89 27 19
MELOXICAM 101 82 28 28
ATORVASTATIN CALCIUM 96 79 29 12
TRIAMTERENE-HCTZ 96 83 29 48
LOVASTATIN 90 83 31 44
NEXIUM 86 57 32 31
TAMSULOSIN HCL 85 82 33 27
ALLOPURINOL 83 68 34 29
SERTRALINE HCL 77 77 35 21
RANITIDINE HCL 75 52 36 38
LANTUS 72 67 37 42
CLOPIDOGREL 70 69 38 34
PRAVASTATIN SODIUM 68 64 39 10
ADVAIR DISKUS 67 45 40 51
FENTANYL 66 55 S2 41 66
ESCITALOPRAM OXALATE 61 50 42 52
LIDOCAINE 60 60 43 314
TRAZODONE HCL 59 58 44 43
PLAVIX 59 59 44 61
PAROXETINE HCL 58 56 46 68
PREDNISONE 58 38 46 40
ACTOS 56 52 48 130
CLONIDINE HCL 55 55 49 64
LEVOFLOXACIN 55 54 49 78
FENOFIBRATE 54 41 51 71
FAMOTIDINE 54 52 51 63
LOSARTAN POTASSIUM 53 51 53 24
POLYETHYLENE GLYCOL 3350 53 53 53 39
METHYLPREDNISOLONE 50 41 55 125
OXYBUTYNIN CHLORIDE ER 50 48 55 126
LOSARTAN-HYDROCHLOROTHIAZIDE 50 45 55 47
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 15, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.